4//SEC Filing
MACKENZIE ALEXANDER R 4
Accession 0001225208-20-003805
CIK 0000078003other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:34 PM ET
Size
14.3 KB
Accession
0001225208-20-003805
Insider Transaction Report
Form 4
PFIZER INCPFE
MACKENZIE ALEXANDER R
Executive Vice President
Transactions
- Award
Common Stock
2020-02-26+21,202→ 101,323 total - Award
Common Stock
2020-02-26+17,087→ 118,410 total - Tax Payment
Common Stock
2020-02-26$34.72/sh−7,984$277,204→ 110,426 total - Tax Payment
Common Stock
2020-02-26$34.72/sh−8,104$281,371→ 102,322 total - Award
Stock Appreciation Rights
2020-02-27+102,221→ 102,221 totalExercise: $34.10From: 2025-02-27Exp: 2025-02-27→ Common Stock (102,221 underlying) - Award
Stock Appreciation Rights
2020-02-27+87,581→ 87,581 totalExercise: $34.10From: 2027-02-27Exp: 2027-02-27→ Common Stock (87,581 underlying)
Holdings
- 9,702(indirect: By Rule 16b-3 Plan)
Common Stock
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
- [F3]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
- [F4]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001678459
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:34 PM ET
- Size
- 14.3 KB